Factbox: Key upcoming clinical trials of hydroxychloroquine, touted by Trump, for COVID-19
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to potential safety risks but other studies testing the medicine are continuing.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: American Health | Clinical Trials | COVID-19 | Health | Hydroxychloroquine | International Medicine & Public Health | Malaria | Study | Trump | USA Health | WHO